ConcertoCare Funding, Investors & Competitors

ConcertoCare has raised $150M across 3 funding rounds, most recently a $105M Series B in February 2022.

Last ConcertoCare funding round

$105M

Series B · Feb 2022

Cumulative funding ConcertoCare raised

$150M

across 3 funding rounds

Key investors in ConcertoCare

  • Deerfield Capital Management
  • Deerfield
  • Highland Capital Partners
  • Obvious Ventures
  • Arboretum Ventures
  • Vast Ventures
  • Wells Fargo Strategic Capital
  • SteelSky Ventures

ConcertoCare Overview

About ConcertoCare

ConcertoCare is a provider of in-home primary care for seniors and adults with complex needs, operating in markets like Connecticut and New York. Its models include house calls, palliative care, and chronic disease management powered by a population health platform. Teams of geriatricians and nurse practitioners coordinate with specialists to serve Medicare patients.


Founded

2015

HQ

United StatesBoston, MA

Status

Privately held

Customer focus

B2C

Revenue model

Services

ConcertoCare Funding History

ConcertoCare has raised a total of $150M across 3 funding rounds.

ConcertoCare's first fundraising round was a $15M undisclosed-stage round in July 2015. The most recent completed round was a $105M Series B in February 2022.

ConcertoCare funding rounds

ConcertoCare funding rounds
DateStageInvestorsRaisedDeal Summary
Feb 2022Series BWells Fargo Strategic Capital (lead); Charles and Lynn Schusterman Family Philanthropies; Deerfield Capital Management; Obvious Ventures; Vast Ventures; SteelSky Ventures; Pennington Partners & Co$105MConcertoCare is a tech-enabled, value-based care provider delivering comprehensive at-home care to seniors and adults with unmet health and social needs, including home-based primary care, palliative care, Programs of All-Inclusive Care for the Elderly (PACE), and services addressing social determinants of health. The company operates in eight states—Washington, Massachusetts, Virginia, New York, Ohio, Florida, California, and Oregon—and partners with Medicare Advantage plans, Medicare-Medicaid plans, CMS value-based programs, physicians, home health, and hospice agencies. Interdisciplinary teams of physicians, nurses, pharmacists, health coaches, mental health professionals, and social workers provide in-person and virtual care for chronic disease management, care coordination, and access to social services like nutritious meals. On February 3, 2022, ConcertoCare closed a $105 million Series B funding round led by Wells Fargo Strategic Capital, with participation from Obvious Ventures, Vast Ventures, The Schusterman Family Foundation (also referred to as Charles and Lynn Schusterman Family Philanthropies), SteelSky Ventures, Pennington Partners & Co, and returning investor Deerfield Management (also noted as Deerfield Capital Management). This brought total equity funding to $149.5 million. The capital supports market expansion, service enhancements in existing markets, PACE program launch, technology investments, and clinician recruitment. This follows a prior merger with Perfect Health, now integrated into ConcertoCare. The company outlined bold 2022 growth goals, including new market entries and deepened value-based payer partnerships, positioning it to serve more complex-care patients amid rising home-based care demand.
Nov 2016Undisclosed stageArboretum Ventures (lead); Deerfield Capital Management (lead); Highland Capital Partners; Deerfield$30M-
Jul 2015Undisclosed stage-$15M-

Who has invested in ConcertoCare?

10 investors have backed ConcertoCare across its funding rounds, including Deerfield Capital Management, Deerfield, Highland Capital Partners, Obvious Ventures, Arboretum Ventures and Vast Ventures.

Lead investors include Wells Fargo Strategic Capital, Arboretum Ventures and Deerfield Capital Management.


ConcertoCare Investors

Investors in ConcertoCare by funding rounds participated
InvestorHQRoundsRoleFirst check
Deerfield Capital ManagementUnited StatesLos Angeles, CA2LeadNov 2016
Charles and Lynn Schusterman Family PhilanthropiesUnited StatesTulsa, OK1ParticipantFeb 2022
Highland Capital PartnersUnited StatesLexington, KY1ParticipantNov 2016
Obvious VenturesUnited StatesSan Francisco, CA1ParticipantFeb 2022
Wells Fargo Strategic CapitalUnited StatesSan Francisco, CA1LeadFeb 2022
Vast VenturesUnited StatesNew York City, NY1ParticipantFeb 2022
Arboretum VenturesUnited StatesAnn Arbor, MI1LeadNov 2016
SteelSky VenturesUnited StatesAtlanta, GA1ParticipantFeb 2022

This data is available for Pro users. Sign up to see all 10 ConcertoCare investors.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

Acquisitions by ConcertoCare

ConcertoCare has acquired 1 company to date.

Last acquisition by ConcertoCare was on February 3rd 2022. ConcertoCare acquired Crown Health for undisclosed valuation.


Latest Acquisitions by ConcertoCare

Crown Health
Description
Crown Health is a provider of in-home primary care for seniors based in Los Angeles, California. The company delivers mobile medical services including check-ups, chronic disease management, and medication reconciliation to homebound patients over age 65. Its physicians and nurse practitioners conduct house calls in Los Angeles County, partnering with Medicare Advantage plans. Launched in 2020, Crown Health focuses on reducing hospital readmissions through telehealth integration and care coordination.
HQ CountryUnited States
HQ City
Seattle, WA
Deal Date3 Feb 2022
Valuationundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all ConcertoCare acquisitions and their M&A valuation multiples.

Start Free Trial

ConcertoCare Competitors

ConcertoCare competitors include listed companies like Max Healthcare Institute and Oscar Health, and private ones like Devoted Health, Ping An Good Doctor, Ro and WeDoctor.

Public and private companies comparable to ConcertoCare
CompanyHQStatusRevenueEBITDAValuationRevenue Multiple
Devoted HealthUnited StatesBoston, MAPrivate$3.3B-$13B4.0x
Max Healthcare InstituteIndiaIndiaPublicly listed$858M$232M$10B10.2x
Oscar HealthUnited StatesUnited StatesPublicly listed$12B($391M)$9.9B0.4x
Ping An Good DoctorChinaShenzhenPrivate$271M-$8.8B32.5x
RoUnited StatesNew York City, NYPrivate$598M-$7B11.7x
WeDoctorChinaHangzhouPrivate$139M-$7B50.4x

ConcertoCare Public Comps

ConcertoCare is still privately-owned, but its public comps include BrightSpring Health, Max Healthcare Institute, Ensign Group, Oscar Health, Hinge Health, Chemed, Hims, National Healthcare Corp, Aveanna Healthcare and Brookdale Senior Living.

Last FYEV/RevenueEV/EBITDA
RevenueEBITDALast FYLTM2027ELast FYLTM2027E
BrightSpring Health$13B$460M1.0x0.9x28.4x16.8x
Max Healthcare Institute$858M$232M12.6x10.2x46.5x36.8x
Ensign Group$5.1B$543M2.4x2.1x22.3x17.5x
Oscar Health$12B($391M)0.5x0.4x(15.9x)12.8x
Hinge Health$588M($522M)12.3x9.3x(13.9x)34.6x
Chemed$2.5B$414M2.7x2.6x16.6x13.7x
Hims$2.3B$178M3.1x2.4x40.4x23.9x
National Healthcare Corp$1.5B$204M2.2x-16.4x-

This data is available for Pro users. Sign up to see all ConcertoCare competitors and their valuation data.

Start Free Trial

Common questions about ConcertoCare

When was ConcertoCare founded?ConcertoCare was founded in 2015.
Where is ConcertoCare headquartered?ConcertoCare is headquartered in Boston, MA, United States.
Is ConcertoCare publicly listed?No, ConcertoCare is a private, VC-backed company.
How much funding has ConcertoCare raised?ConcertoCare has raised $150M across 3 funding rounds.
What was ConcertoCare's last funding round?ConcertoCare's last funding round was a $105M Series B in February 2022, led by Wells Fargo Strategic Capital.
Who are ConcertoCare's investors?ConcertoCare's investors include Deerfield Capital Management, Charles and Lynn Schusterman Family Philanthropies, Highland Capital Partners, Obvious Ventures, Wells Fargo Strategic Capital, Vast Ventures, Arboretum Ventures, SteelSky Ventures, Pennington Partners & Co and Deerfield.
Which companies are comparable to ConcertoCare?Companies comparable to ConcertoCare include Devoted Health, Max Healthcare Institute, Oscar Health, Ping An Good Doctor, Ro and WeDoctor.
How many companies has ConcertoCare acquired?ConcertoCare has acquired 1 company, including Crown Health.

See companies similar to ConcertoCare

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial